Alto Neuroscience, Inc. 8-K

What Happened

• Alto Neuroscience, Inc. announced and furnished a press release reporting its financial results for the fiscal quarter ended March 31, 2026. The company filed the Current Report on Form 8‑K on May 13, 2026 (Item 2.02: Results of Operations and Financial Condition) and incorporated the press release as Exhibit 99.1.

Key Details

• Filing date: May 13, 2026 (Form 8‑K).
• Reporting period: fiscal quarter ended March 31, 2026.
• The press release containing the results is furnished as Exhibit 99.1 to the 8‑K (Item 9.01 lists exhibits).
• The report was signed by Amit Etkin, M.D., Ph.D., President and Chief Executive Officer.

Why It Matters

• This 8‑K notifies investors that Alto has publicly released its latest quarterly results; investors should review the attached press release (Exhibit 99.1) or the full filing on SEC EDGAR for the specific financial figures and management commentary. The filing itself does not present detailed financial statements within the 8‑K beyond furnishing the press release.